CWM
LAB icon

CIBC World Markets’s Standard BioTools LAB Stock Holding History

CIBC World Markets’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$25.3K Buy
+19,803
New +$26.6K ﹤0.01% 1222
2025
Q2 		$44.3K Sell
36,882
-28,572
-44% -$31.7K ﹤0.01% 1485
2025
Q1 		$70.7K Buy
65,454
+37,848
+137% +$53.1K ﹤0.01% 1668
2024
Q4 		$48.3K Buy
+27,606
New +$51.4K ﹤0.01% 1257

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

CIBC World Markets's LAB Position: Q4 2025 in Review

CIBC World Markets opened a new position in Standard BioTools (LAB) in Q4 2025: 19,803 shares worth $25.3K. The stake represents ﹤0.01% of the portfolio and ranks #1222 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in LAB as recently as Q2 2025.

CIBC World Markets first reported a position in LAB in Q4 2024 and has held it in 4 quarters since. The position peaked at $70.7K in Q1 2025. 159 funds tracked by Wall St. Rank hold LAB as of Q4 2025.

  • CIBC World Markets held 19,803 shares of Standard BioTools worth $25.3K as of Q4 2025.
  • Standard BioTools was a new CIBC World Markets position in Q4 2025.
  • Standard BioTools made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1222 holding.
  • CIBC World Markets first reported a position in Standard BioTools in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Standard BioTools position peaked at $70.7K in Q1 2025.
  • 159 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.